Hepion Pharmaceuticals, Inc.
HEPA· OTC
HEPAHepion Pharmaceuticals, Inc.
Source filing unavailable
| Metric | Q2 2017 | Q2 2015 | Q2 2014 |
|---|---|---|---|
| Net Income | $2.05M | -$3.10M | -$168.16K |
| EPS Diluted | $0.27 | -$0.36 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
